Geode Capital Management
PCVX icon

Geode Capital Management’s Vaxcyte PCVX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$97.9M Buy
3,011,140
+142,086
+5% +$4.62M 0.01% 1041
2025
Q1
$108M Buy
2,869,054
+66,166
+2% +$2.5M 0.01% 934
2024
Q4
$229M Buy
2,802,888
+102,106
+4% +$8.36M 0.02% 589
2024
Q3
$309M Buy
2,700,782
+259,010
+11% +$29.6M 0.03% 510
2024
Q2
$184M Buy
2,441,772
+154,397
+7% +$11.7M 0.02% 623
2024
Q1
$156M Buy
2,287,375
+313,869
+16% +$21.4M 0.01% 693
2023
Q4
$124M Buy
1,973,506
+98,392
+5% +$6.18M 0.01% 745
2023
Q3
$95.6M Buy
1,875,114
+189,900
+11% +$9.68M 0.01% 823
2023
Q2
$84.2M Buy
1,685,214
+355,875
+27% +$17.8M 0.01% 898
2023
Q1
$49.8M Buy
1,329,339
+77,906
+6% +$2.92M 0.01% 1190
2022
Q4
$60M Buy
1,251,433
+356,647
+40% +$17.1M 0.01% 1026
2022
Q3
$21.5M Buy
894,786
+115,091
+15% +$2.76M ﹤0.01% 1675
2022
Q2
$17M Buy
779,695
+57,732
+8% +$1.26M ﹤0.01% 1871
2022
Q1
$17.4M Buy
721,963
+66,246
+10% +$1.6M ﹤0.01% 1987
2021
Q4
$15.6M Buy
655,717
+25,150
+4% +$598K ﹤0.01% 2128
2021
Q3
$16M Buy
630,567
+111,593
+22% +$2.83M ﹤0.01% 2114
2021
Q2
$11.7M Buy
518,974
+98,086
+23% +$2.21M ﹤0.01% 2350
2021
Q1
$8.31M Buy
420,888
+120,311
+40% +$2.38M ﹤0.01% 2479
2020
Q4
$7.99M Buy
300,577
+8,164
+3% +$217K ﹤0.01% 2312
2020
Q3
$14.4M Buy
292,413
+266,887
+1,046% +$13.2M ﹤0.01% 1743
2020
Q2
$806K Buy
+25,526
New +$806K ﹤0.01% 3210